Accent Therapeutics procures $40 mln Series A
Lexington, Massachusetts-based Accent Therapeutics, a biopharmaceutical company focused on treating cancer patients, has raised $40 million in Series A funding. The investors were The Column Group, Atlas Venture and EcoR1 Capital.
18 May 2018•1 min read
